Connecting our world at UW Medicine

COVID-19 News Update for May 13, 2021

Data Snapshot  

UW Medicine Hospitals:  

King County: The county reported 285 new positive cases and 5 new deaths on May 13.  

Washington: The state reported 385,762 cases and 5,614 deaths as of May 11.  

United States: The CDC reports 32,608,287 cases and 580,073 deaths as of May 13. 

Global: WHO reports 160,074,267 confirmed COVID-19 cases and 3,325,260 deaths as of May 13. 

Numbers update frequently, please follow links for most up-to-date numbers.  

UW Medicine COVID-19 Vaccine Distribution Update 

Total Vaccine Doses Administered: 278,005 

  • Total first dose: 148,425 
  • Total second dose: 129,580 

As of May 11, 2021. 

UW Medicine in the News

KOMO: Washington teens could get Pfizer COVID-19 vaccine as early as Thursday if CDC approves
Featuring: Anna Wald, Allergy and Infectious Diseases; Doug Diekman, Pediatrics
University of Washington Medicine Professor of Pediatrics and Seattle Children’s Physician Doug Diekema said the Pfizer vaccine is critical in protecting children from coronavirus. ‘We see the sicker ones and some of them are extraordinarily sick and some of them are left with long-lasting impacts even after they’re recovered,’ Diekema said. Diekema said side effects from the Pfizer vaccine are similar between adults and teens. ‘Maybe just a little tired, need a nap, be a little sore, have a little headache – but then, they’re fine,’ said Diekema. UW Medicine Professor and Head of Allergy and Infectious Diseases Division Anna Wald said long-term adverse events from vaccines are extremely rare. She said the children in the trial were followed long enough to ensure the shot was safe.”

The New York Times: Is It Covid or the Flu? New Combo Tests Can Find Out
Featuring: Geoffrey Baird, Laboratory Medicine
“Although last year’s flu season was nonexistent, Dr. Geoffrey Baird of the University of Washington in Seattle said that a confluence of factors might precipitate its return in the fall: children returning to school buildings, declining use of masks and perhaps a lack of recent immune system exposure to the flu. If more people get sick in the fall, he added, they will want to know if it is flu or the coronavirus. ‘We in the laboratory are preparing for another big boom in testing,’ said Dr. Baird, whose team has run more than two million coronavirus tests since the beginning of the pandemic. ‘Even if people are vaccinated, they’re going to wonder, ‘Am I the breakthrough case?’”

Bloomberg News: Can Perks Sway the Vaccine-Hesitant?
Featuring: Nancy Jecker, Bioethics & Humanities
“For those already nervous about vaccine side effects or safety, payments could make the shot seem more risky. And introducing financial motivations could erode one of the clearest, most fundamental arguments for vaccination—that personal immunity benefits the collective good—in favor of a more selfish perk. Nancy Jecker, a professor of bioethics at the University of Washington School of Medicine, is concerned that the practice may also have an outsized coercive effect on lower-income groups and reinforce societal inequities.”  

COVID-19 Literature Report  

COVID-19 Literature Situation Reportis a daily (M-F) newsletter put together by the Alliance for Pandemic Preparedness that provides a succinct summary of the latest scientific literature related to the COVID-19 pandemic.

Key Takeaways: COVID-19 Literature Situation Report May 11, 2021 

  • COVID-19 patients with type 2 diabetes were at a greater than 2-fold elevated risk of COVID-19-related hospitalization, admission to ICU, and death compared to age- and sex- matched controls in a nationwide study in Sweden. COVID-19 patients with type 1 diabetes were at similarly increased risk when compared to matched controls, but unlike type 2 diabetes, there was no independent risk after adjustment for sociodemographic factors, pharmacological treatment, and comorbidities.  More. 
  • US patients diagnosed with COVID-19 (n=537,913) had 6.6-fold higher risk of being diagnosed with cerebral venous thrombosis (CVT) and 7.7-fold higher risk of portal vein thrombosis (PVT) within two weeks of COVID-19 diagnosis compared to age-, sex-, and race-matched individuals vaccinated with COVID-19 mRNA vaccines (n=366,869). COVID-19 patients were also at elevated risk for CVT and PVT compared to matched influenza patients. More. 
  • 79% of US adults over age 65 have received at least 1 dose of a COVID-19 vaccine as of April 10, 2021. On average, counties with low vaccination initiation rates had higher proportions of socially vulnerable adults compared with counties with high vaccination rates. More. 

COVID-19 Literature Surveillance Team, is an affiliated group of medical students, PhDs and physicians keeping up with the latest research on SARS-CoV-2 / COVID-19 by finding the newest articles, reading them, grading their level of evidence and bringing you the bottom line. 

Read the latest report: May 7 | Weekly COVID-19 LST Report. 

Tweet of the Week   

 

Recent Posts